Apollo Hospitals Enterprise Ltd

Apollo Hospitals Enterprise Ltd

$APOLLOHOSPHospitalNSEBSE

Apollo Hospitals Enterprise Ltd (APOLLOHOSP) last traded at ₹8,798, a market capitalisation of ₹1,26,495 crore, on a P/E of 60.1. Over the past 52 weeks the stock has ranged between ₹6,680 and ₹9,327. Apollo Hospitals Enterprise Ltd last reported results for the quarter ended Jun 2026, with sales of ₹7,044 crore and net profit of ₹610 crore. Apollo Hospitals Enterprise Ltd’s annual general meeting is scheduled for 25 Aug 2026. Figures are as of 25 Aug 2026 and are not real time.

Apollo Hospitals Enterprise Ltd share price and key metrics

Current price
₹8,798
Market cap
₹1,26,495 cr
Stock P/E
60.1
Book value
₹659
ROE
21.2%
ROCE
17.4%
Dividend yield
0.23%
52w high / low
9327/6680

Metrics as of 25 Aug 2026. Not real time.

Apollo Hospitals Enterprise Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹7,044 cr, up 20.6% from ₹5,842 cr a year earlier. Net profit was ₹610 cr, up 38.3% year on year.

Apollo Hospitals Enterprise Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales5,5895,5275,5925,8426,3046,4776,6067,044
Expenses4,7744,7654,8224,9905,3625,5125,5945,951
Operating profit8167627708529419651,0111,092
OPM %15%14%14%15%15%15%15%16%
Other income4469725461485462
Interest118110115108110113119120
Depreciation184185211215218219224235
Profit before tax557536516583675682722799
Tax %29%29%20%24%27%24%24%24%
Net profit396379414441494516551610
EPS (₹)26.3425.8927.1030.1033.1934.9336.8140.39

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Apollo Hospitals Enterprise Ltd annual results

Apollo Hospitals Enterprise Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales10,56014,66316,61219,05921,79425,22826,430
Operating profit1,1402,1892,0652,3943,0333,7794,010
OPM %11%15%12%13%14%15%15%
Net profit1371,1088449351,5052,0032,172
EPS (₹)10.4673.4256.9762.50100.56135.04145.32

TTM is the trailing twelve months to the most recent quarter.

Apollo Hospitals Enterprise Ltd growth and returns

Compounded Sales Growth
10 Years
15%
5 Years
19%
3 Years
15%
TTM
17%
Compounded Profit Growth
10 Years
23%
5 Years
76%
3 Years
32%
TTM
34%
Stock Price CAGR
10 Years
20%
5 Years
13%
3 Years
21%
1 Year
11%
Return on Equity
10 Years
13%
5 Years
17%
3 Years
18%
Last Year
21%

Apollo Hospitals Enterprise Ltd shareholding pattern

Promoters held 28.02% at Jun 2026, down from 29.34% at Jun 2025. FIIs 41.49% and DIIs 23.72%.

Apollo Hospitals Enterprise Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters29.33%29.33%29.34%29.34%28.02%28.02%28.02%28.02%
FIIs45.37%45.27%42.74%43.49%44.20%43.54%42.62%41.49%
DIIs19.94%19.97%22.29%21.34%21.12%21.50%22.76%23.72%
Government0.23%0.23%0.23%0.23%0.23%0.23%0.23%0.23%
Public5.12%5.21%5.41%5.61%6.43%6.71%6.39%6.53%
No. of shareholders1,19,2451,27,8021,34,0581,41,0071,60,5561,78,6481,74,6101,74,281

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

When is Apollo Hospitals Enterprise Ltd’s AGM?

Apollo Hospitals Enterprise Ltd’s annual general meeting is scheduled for 25 Aug 2026.

  • AGM45th Annual General Meeting proceedings and voting results
  • AGM45th Annual General Meeting, including dividend declaration

See the full results calendar for every Indian company reporting in the next 30 days.

Apollo Hospitals Enterprise Ltd corporate filings

  • Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Apollo Hospitals Enterprise Ltd has filed the outcome of its analyst/investor meeting…

    Read the full analysis
  • Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Apollo Hospitals has filed the outcome of its analyst/investor meeting held on August 13…

    Read the full analysis
  • Announcement under Regulation 30 (LODR)-Investor PresentationCompany Updatehigh impact
    Filing PDF

    Cruxal's analysis: Apollo Hospitals Enterprise Limited reported robust Q1 FY27 consolidated financial…

    Read the full analysis
  • Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Apollo Hospitals has issued an intimation regarding an upcoming analyst/investor meeting…

    Read the full analysis
  • Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Apollo Hospitals has filed a press release under Regulation 30 of the SEBI (LODR)…

    Read the full analysis
  • Outcome Of The Board Meeting - Financial ResultsResulthigh impact
    Filing PDF

    Cruxal's analysis: Apollo Hospitals Enterprise Limited reported robust Q1 FY27 financial results, with…

    Read the full analysis
  • Notice Published In News Papers - 45Th AGM And Evoting Related Information; Record Date For Payment Of Dividend EtcCompany Updatemedium impact
    Filing PDF

    Cruxal's analysis: Apollo Hospitals Enterprise Limited has announced the recommendation of a final dividend…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Apollo Hospitals Enterprise Ltd

Cruxal reads every Apollo Hospitals Enterprise Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.

Apollo Hospitals Enterprise Ltd (APOLLOHOSP) Results, Financials & Share Price | Cruxal